News | March 14, 2023
Briefs: Lupin and Alembic
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
The company will be submitting the responses to US FDA observations within stipulated timeline
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Marksans' OTC Famotidine Tablets USP are acid reducers
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
